about
Cellular immune response to Plasmodium falciparum after pregnancy is related to previous placental infection and parityIntermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trialEconomic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancyMortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort StudyConsequences of gestational malaria on birth weight: finding the best timeframe for intermittent preventive treatment administrationIron and malaria: a dangerous liaison?Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children.The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data[Clinical research on malaria: what for the future?][Multiple imputation of missing at random data: General points and presentation of a Monte-Carlo method].Can treatment of malaria be restricted to parasitologically confirmed malaria? A school-based study in Benin in children with and without fever.Incidence of malaria-related fever and morbidity due to Plasmodium falciparum among HIV1-infected pregnant women: a prospective cohort study in South BeninResisting and tolerating P. falciparum in pregnancy under different malaria transmission intensitiesPregnancy-associated malaria and malaria in infants: an old problem with present consequencesInfections in infants during the first 12 months of life: role of placental malaria and environmental factorsWhat would PCR assessment change in the management of fevers in a malaria endemic area? A school-based study in Benin in children with and without fever.Spontaneous postpartum clearance of Plasmodium falciparum parasitemia in pregnant women, Benin.Prevention of malaria during pregnancy: assessing the effect of the distribution of IPTp through the national policy in Benin.Predictive factors of plasma HIV suppression during pregnancy: a prospective cohort study in Benin.Malaria associated symptoms in pregnant women followed-up in BeninImpact of pregnancy-associated malaria on infant malaria infection in southern Benin.Influence of the timing of malaria infection during pregnancy on birth weight and on maternal anemia in BeninImpact of helminth infection during pregnancy on cognitive and motor functions of one-year-old childrenMaternal anemia in Benin: prevalence, risk factors, and association with low birth weightMolecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.Malaria in Pregnancy Is a Predictor of Infant Haemoglobin Concentrations during the First Year of Life in Benin, West AfricaIs chloroquine chemoprophylaxis still effective to prevent low birth weight? Results of a study in BeninSulfadoxine/pyrimethamine intermittent preventive treatment for malaria during pregnancyFirst malaria infections in a cohort of infants in Benin: biological, environmental and genetic determinants. Description of the study site, population methods and preliminary results.Elevated Blood Lead Levels Are Associated with Reduced Risk of Malaria in Beninese InfantsInsights Into Circulating Cytokine Dynamics During Pregnancy in HIV-Infected Beninese Exposed to Plasmodium falciparum Malaria.Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and TolerabilityDoes Iron Increase the Risk of Malaria in Pregnancy?Maternal anemia at first antenatal visit: prevalence and risk factors in a malaria-endemic area in Benin.Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas.Malaria and gravidity interact to modify maternal haemoglobin concentrations during pregnancy.Maternal anemia in pregnancy: assessing the effect of routine preventive measures in a malaria-endemic area.Elevated Blood Lead Levels in Infants and Mothers in Benin and Potential Sources of ExposureRelation between Plasmodium falciparum asymptomatic infection and malaria attacks in a cohort of Senegalese childrenYoung adolescent girls are at high risk for adverse pregnancy outcomes in sub-Saharan Africa: an observational multicountry study.
P50
Q24799346-FE7B33BB-B867-4F08-8160-078386734C10Q28543146-B65B2999-4806-4EC7-AAA1-6F2E1CF941D1Q28546725-78247D7E-AE04-4C4B-AE78-596D81DC368FQ28550346-007CD478-C5F5-4F48-99BF-3EBC7B20AF4BQ28730587-3A7238D0-6F35-40C0-889F-FAB956B6C003Q30248273-9AB0F6FD-32D7-48FA-A7B2-0AFDEC8F885AQ30757681-980B1C78-FF2D-48D0-B345-88EC741FECDFQ30936416-79955180-1846-485D-B770-87DB8C65BC7FQ33225240-F33A8847-AAAB-4575-9778-D00D5E750D9DQ33493011-D87FC2F3-1E51-46F9-B8E9-F89BCDD3E94AQ33846633-9A7B741A-6A99-434F-9CD3-5BF4A1A582C3Q33874151-2CD01653-E52E-47F9-9B7F-4137003C6848Q33910163-B59AA205-3768-4E6F-9438-6303D661AC63Q33963392-8269B2D3-F019-485A-80B7-E257A23369FBQ34077950-B2547790-1EBE-4579-8A2C-66B0C2D1F732Q34078349-9EE1D11D-C5E1-4F68-B475-514195EB383CQ34531233-BE6F2CA0-06D1-48B8-8FC1-4CFA2992DED5Q34531242-6AB22A4F-7CC7-4C91-A463-CA31B9E79D60Q34649171-D6408C85-6871-487D-A2FF-11E7BE46E3FFQ34790559-1EB3B9A8-8BFA-4CB6-9330-65F2C45EBE05Q35043984-B9140B2F-D7D6-49C0-B73D-B78F2AE1112FQ35131357-C55C6066-1A37-4BF8-934F-BEF4ED7D18E3Q35165431-28DBE747-59BA-443D-8C05-0DD7D2427B2CQ35186784-D02E463B-5A2B-4453-9156-153040666132Q35428566-029C10C2-D5EF-4180-A6CB-363A36EA1C08Q35656026-DECCBD78-2C92-406B-A7F7-A149D53850EAQ35677598-DF555F8E-78EC-438D-AA6B-4366677DD9BFQ35805015-5C822FDD-7DBE-4293-8083-EA02CCEA3F91Q35819766-C6A2DF11-8C0C-48A8-9135-5CD5BBC6B1B6Q35920561-BEB80882-C2CF-4017-B136-B4500B2807F4Q35933924-335A244D-D00C-4848-8D46-BFE00DCCEC98Q35933939-CD1B2996-D075-4C0A-A334-57F965B858BAQ36051953-7011B5FD-C484-4282-AD8E-D5416EF9BDADQ36213220-89E55A07-7B85-4B36-A343-255F7B1E74F4Q36316144-D04891F5-A5D1-4E8C-9B36-116F09EF4851Q36462673-D9293EE3-2572-4BFE-B7AB-7DB154A28AC6Q36641790-B0815CBE-6BE8-498E-A402-9A61CDDE247BQ36732502-8664BC53-CD49-472B-A98B-26847FB4FF99Q36936686-2368EDE5-32C5-4765-8A67-0BA803BDD574Q37063702-22C27D78-47C0-4764-A3B1-3A44427E62D9
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Michel Cot
@ast
Michel Cot
@en
Michel Cot
@es
Michel Cot
@nl
Michel Cot
@sl
type
label
Michel Cot
@ast
Michel Cot
@en
Michel Cot
@es
Michel Cot
@nl
Michel Cot
@sl
prefLabel
Michel Cot
@ast
Michel Cot
@en
Michel Cot
@es
Michel Cot
@nl
Michel Cot
@sl
P1006
P214
P244
P1006
P1053
E-7633-2011
P106
P21
P213
0000 0001 1782 8910
P214
P244
nr96032615
P31
P3829
P496
0000-0003-3014-4294
P569
2000-01-01T00:00:00Z
P735
P7859
lccn-nr96032615